Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$29.09 -0.19 (-0.65%)
As of: Sep 30, 2026 · 10:22 AM EDT

Amylyx Pharmaceuticals (AMLX) Finished Goods (2022)

Updated

Amylyx Pharmaceuticals (AMLX) posted Finished Goods of $937,000 for Q4 2022, up 751.8% from the prior quarter.

Analysis

Amylyx Pharmaceuticals (AMLX) Finished Goods (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Amylyx Pharmaceuticals 3.32 Bn 3.32 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 937,000.00
Sep 30, 2022 110,000.00
API Access

Amylyx Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=AMLX&period=max&api_key=YOUR_API_KEY